To investigate further, we used CD8-cre mice to achieve CD8+ T cell–specific GPX4 cKO (CD8-cre+gpx4fl/fl), revealing sufficient suppression of tumor growth by host GPX4-deficient CD8+ T cells (Figure 1L). This evidence concerns the gene CD8A and neoplasm.